esketamine has been researched along with Schizophrenia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Curic, S; Haaf, M; Leicht, G; Mulert, C; Rauh, J; Steinmann, S | 1 |
| Adelino, MPM; Ajub, E; Lacerda, ALT; Nunes, MV; Quarantini, LC | 1 |
2 other study(ies) available for esketamine and Schizophrenia
| Article | Year |
|---|---|
Opposite Modulation of the NMDA Receptor by Glycine and S-Ketamine and the Effects on Resting State EEG Gamma Activity: New Insights into the Glutamate Hypothesis of Schizophrenia.
Topics: Biomarkers; Electroencephalography; Glutamic Acid; Humans; Ketamine; Male; N-Methylaspartate; Receptors, N-Methyl-D-Aspartate; Schizophrenia | 2023 |
Efficacy of esketamine in the treatment of negative symptoms in schizophrenia - A case series.
Topics: Adult; Excitatory Amino Acid Antagonists; Female; Humans; Ketamine; Male; Middle Aged; Receptors, N-Methyl-D-Aspartate; Schizophrenia; Treatment Outcome; Young Adult | 2018 |